Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sawai Pharmaceutical Co Ltd (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11529
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company’s products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution, and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.

Sawai Pharmaceutical Co Ltd (4555) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Partnerships 14
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Equity Offering 21
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Asset Transactions 22
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Acquisition 24
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million 28
Sawai Pharmaceutical Co Ltd – Key Competitors 30
Sawai Pharmaceutical Co Ltd – Key Employees 31
Sawai Pharmaceutical Co Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Corporate Communications 33
May 15, 2018: Sawai Pharmaceutical Announce Personnel Changes 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million 28
Sawai Pharmaceutical Co Ltd, Key Competitors 30
Sawai Pharmaceutical Co Ltd, Key Employees 31
Sawai Pharmaceutical Co Ltd, Subsidiaries 32

List of Figures
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gebr. Heinemann SE & Co. KG:戦略・SWOT・企業財務分析
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Glythera Ltd (Glythera) is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company develops antibody-based therapies for the treatment of cancer and broader based therapeutics. It uses its proprie …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Arkady Novikov Restaurant Group:企業の戦略・SWOT・財務分析
    Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report Summary Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • General Mills Inc:企業のM&A・事業提携・投資動向
    General Mills Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's General Mills Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • HollyFrontier Corp (HFC):企業の財務・戦略的SWOT分析
    HollyFrontier Corp (HFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Johnson Controls International Plc (JCI):電力:M&Aディール及び事業提携情報
    Summary Johnson Controls International Plc (Johnson Controls) is a diversified technology and multi industrial company. It creates intelligent buildings, integrated infrastructure, efficient energy solutions, and next generation transportation systems. The company provides HVAC equipment, HVAC contr …
  • Pon Holdings B.V.:企業のM&A・事業提携・投資動向
    Pon Holdings B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pon Holdings B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • China General Technology (Group) Holding Ltd:企業の戦略・SWOT・財務分析
    China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Aston Martin Lagonda Global Holdings plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • SolarWinds North America Inc:企業の戦略的SWOT分析
    SolarWinds North America Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Royal Orchid Hotels Ltd:企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GfK SE:企業の戦略・SWOT・財務情報
    GfK SE - Strategy, SWOT and Corporate Finance Report Summary GfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Probe Scientific Ltd-医療機器分野:企業M&A・提携分析
    Summary Probe Scientific Ltd (Probe Scientific) is a medical device company that develops products to solve clinical issues. The company offers products, which include microeye, continumon and nanoeye, among others. Its microeye is a sampling device for monitoring substances such as electrolytes, am …
  • Hansgrohe SE:企業の戦略・SWOT・財務情報
    Hansgrohe SE - Strategy, SWOT and Corporate Finance Report Summary Hansgrohe SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Iroko Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Iroko Pharmaceuticals LLC (Iroko) is a pharmaceutical company that develops treatment options for responsible pain management. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of nonclinic …
  • Scottish Enterprise:電力:M&Aディール及び事業提携情報
    Summary Scottish Enterprise is a business consulting firm that Supports firms to raise wage levels. The firm provides service such as attract investment, develop management team, do business outside Scotland, develop organization, develop new products and services, among others. It offers service su …
  • Msc Industrial Direct Co., Inc.
    Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Celgene Corporation:企業のM&A・事業提携・投資動向
    Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celgene Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Otsuka Pharmaceutical Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆